KLAC Stock Analysis: KLA | NASDAQ
Semiconductor Equipment & Materials | NASDAQ, USA | Market Cap: 236.015m USD | 12M Return: 70% | US4824801009 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.54B
EPS Trend: 96.4%
Qual. Beats: 2
Rev. Trend: 95.7%
Qual. Beats: 8
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
KLA Corporation provides process control and process-enabling solutions used in the manufacturing of wafers, reticles, integrated circuits, packaged ICs, and printed circuit boards. The company operates through three segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB and Component Inspection. Its offerings include defect inspection and review tools, metrology systems, chemical process control equipment, wafer processing technologies (etch, plasma dicing, deposition), and direct imaging and additive printing solutions for PCB production. KLA also generates recurring revenue through service programs supporting its installed base.
The company serves semiconductor and electronic device manufacturers and has a globally diversified footprint spanning China, Taiwan, Korea, North America, Japan, Europe, Israel, and the rest of Asia. KLA was incorporated in 1975, is headquartered in Milpitas, California, and adopted its current name in July 2019 after previously operating as KLA-Tencor.
As a member of the Semiconductor Materials & Equipment sub-industry, KLA occupies a specialized niche within the chip supply chain: its tools are deployed by foundries, memory producers, and IDMs at multiple stages of wafer fabrication to identify and classify defects, supporting yield management and process qualification. The semiconductor process control segment is a highly concentrated market, with KLA recognized as a leading supplier of inspection and metrology equipment to chipmakers worldwide.
- China semiconductor equipment demand drives Semiconductor Process Control revenue
- AI chip capex lifts wafer inspection and metrology system orders
- Specialty Semiconductor Process margins under pressure from packaging competition
| Net Income: 4.83b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA -2.31 > 1.0 |
| NWC/Revenue: 59.48% < 20% (prev 54.40%; Δ 5.08% < -1%) |
| CFO/TA 0.23 > 3% & CFO 4.14b > Net Income 4.83b |
| Net Debt (1.51b) to EBITDA (5.76b): 0.26 < 3 |
| Current Ratio: 2.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.32b) vs 12m ago -0.58% < -2% |
| Gross Margin: 61.30% > 18% (prev 60.91%; Δ 0.39% > 0.5%) |
| Asset Turnover: 79.83% > 50% (prev 75.65%; Δ 4.18% > 0%) |
| Interest Coverage Ratio: 19.90 > 6 (EBIT TTM 5.66b / Interest Expense TTM 284.4m) |
| A: 0.45 (Total Current Assets 12.4b - Total Current Liabilities 4.30b) / Total Assets 18.0b |
| B: 0.21 (Retained Earnings 3.68b / Total Assets 18.0b) |
| C: 0.33 (EBIT TTM 5.66b / Avg Total Assets 17.0b) |
| D: 0.55 (Book Value of Equity 6.35b / Total Liabilities 11.6b) |
| Altman-Z'' = 6.43 = AAA |
| DSRI: 1.06 (Receivables 2.89b/2.43b, Revenue 13.6b/12.2b) |
| GMI: 0.99 (GM 60.91% / 61.30%) |
| AQI: 0.91 (AQ_t 0.23 / AQ_t-1 0.26) |
| SGI: 1.12 (Revenue 13.6b / 12.2b) |
| TATA: 0.04 (NI 4.83b - CFO 4.14b) / TA 18.0b) |
| Beneish M = -2.94 (Cap -4..+1) = A |
As of September 19, 2026, the stock is trading at USD 176.99 with a total of 20,068,285 shares traded. Over the past week, the price has changed by -2.02%, over one month by -9.14%, over three months by -31.73% and over the past year by +70.01%.
Current recommended Stop Loss: 158.70 (which is 10.3% or 1.7 ATR below the current price).
KLA has received a consensus analysts rating of 4.07. Therefore, it is recommended to buy KLAC.
- StrongBuy: 14
- Buy: 5
- Hold: 10
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 233.8 | 32.1% |
P/E Trailing = 49.2207
P/E Forward = 32.7869
P/S = 17.3802
P/B = 36.4568
P/EG = 1.6941
Revenue TTM = 13.6b USD
EBIT TTM = 5.66b USD
EBITDA TTM = 5.76b USD
Long Term Debt = 5.89b USD (from longTermDebt, last quarter)
Short Term Debt = 52.9m USD (from shortTermDebt, last quarter)
Debt = 6.42b USD (from shortLongTermDebtTotal, last quarter) + Leases 264.3m
Net Debt = 1.51b USD (calculated: Debt 6.42b - CCE 4.90b)
Enterprise Value = 238b USD (236b + Debt 6.42b - CCE 4.90b)
Interest Coverage Ratio = 19.90 (Ebit TTM 5.66b / Interest Expense TTM 284.4m)
EV/FCF = 63.05x (Enterprise Value 238b / FCF TTM 3.77b)
FCF Yield = 1.59% (FCF TTM 3.77b / Enterprise Value 238b)
FCF Margin = 27.74% (FCF TTM 3.77b / Revenue TTM 13.6b)
Net Margin = 35.57% (Net Income TTM 4.83b / Revenue TTM 13.6b)
Gross Margin = 61.30% ((Revenue TTM 13.6b - Cost of Revenue TTM 5.26b) / Revenue TTM)
Gross Margin QoQ = 61.36% (prev 61.12%)
Tobins Q-Ratio = 13.23 (Enterprise Value 238b / Total Assets 18.0b)
Interest Expense / Debt = 4.43% (Interest Expense 284.4m / Debt 6.42b)
Taxrate = 13.83% (775.2m / 5.61b)
NOPAT = 4.88b (EBIT 5.66b * (1 - 13.83%))
Current Ratio = 2.88 (Total Current Assets 12.4b / Total Current Liabilities 4.30b)
Debt / Equity = 1.01 (Debt 6.42b / totalStockholderEquity, last quarter 6.35b)
Debt / EBITDA = 0.26 (Net Debt 1.51b / EBITDA 5.76b)
Debt / FCF = 0.40 (Net Debt 1.51b / FCF TTM 3.77b)
Total Stockholder Equity = 5.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 28.40% (Net Income 4.83b / Total Assets 18.0b)
RoE = 85.38% (Net Income TTM 4.83b / Total Stockholder Equity 5.66b)
RoCE = 49.03% (EBIT 5.66b / Capital Employed (Equity 5.66b + L.T.Debt 5.89b))
RoIC = 37.46% (NOPAT 4.88b / Invested Capital 13.0b)
WACC = 13.16% (E(236b)/V(242b) * Re(13.41%) + D(6.42b)/V(242b) * Rd(4.43%) * (1-Tc(0.14)))
Discount Rate = 13.41% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -97.10 | Cagr: -1.28%
[DCF] Terminal Value 60.65% ; FCFF base≈3.76b ; Y1≈3.79b ; Y5≈4.06b
[DCF] Fair Price = 25.40 (EV 34.7b - Net Debt 1.51b = Equity 33.2b / Shares 1.31b; r=13.16% [WACC]; 5y FCF grow 0.62% → 2.50% )
EPS Correlation: 96.42 | EPS CAGR: 23.61% | SUE: 2.27 | # QB: 2
Revenue Correlation: 95.66 | Revenue CAGR: 14.52% | SUE: 1.78 | # QB: 8
EPS current Quarter (2026-09-30): EPS=1.18 | Chg30d=+0.00% | Revisions=+79% | Analysts=22
EPS next Quarter (2026-12-31): EPS=1.36 | Chg30d=+0.00% | Revisions=+78% | Analysts=22
EPS current Year (2027-06-30): EPS=5.45 | Chg30d=+0.12% | Revisions=+81% | GrowthEPS=+45.1% | GrowthRev=+33.4%
EPS next Year (2028-06-30): EPS=6.71 | Chg30d=+2.03% | Revisions=+61% | GrowthEPS=+22.9% | GrowthRev=+18.2%
[Analyst] Revisions Ratio: +84% (up=74, down=5)